SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-012131
Filing Date
2024-04-16
Accepted
2024-04-16 08:00:56
Documents
16
Period of Report
2024-04-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20240415_8k.htm   iXBRL 8-K 25302
2 EXHIBIT 99.1 ex_654179.htm EX-99.1 10696
7 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-24-012131.txt   184040

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240416.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240416_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240416_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240416_pre.xml EX-101.PRE 12458
19 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240415_8k_htm.xml XML 3058
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 24846140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)